§ Mr. Ashleyasked the Secretary of State for Social Services whether the prices negotiated for National Health Service drugs include an allowance for the risk of drug damage for which the company would have to pay compensation.
§ Mr. NewtonCosts of pharmaceutical companies accepted for the purposes of the pharmaceutical price regulation scheme, and thus reflected in National Health Service medicine prices, would include a due share of the cost of a company's product liability insurance premiums.